FI893916A0 - Alfa-subenhet av lfa-1 -leukocytadhesionsreceptor. - Google Patents

Alfa-subenhet av lfa-1 -leukocytadhesionsreceptor.

Info

Publication number
FI893916A0
FI893916A0 FI893916A FI893916A FI893916A0 FI 893916 A0 FI893916 A0 FI 893916A0 FI 893916 A FI893916 A FI 893916A FI 893916 A FI893916 A FI 893916A FI 893916 A0 FI893916 A0 FI 893916A0
Authority
FI
Finland
Prior art keywords
molecules
lfa
subenhet
leukocytadhesionsreceptor
alfa
Prior art date
Application number
FI893916A
Other languages
English (en)
Other versions
FI893916A (fi
Inventor
Timothy Alan Springer
Richard Larson
Original Assignee
Dana Farber Cancer Inst Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dana Farber Cancer Inst Inc filed Critical Dana Farber Cancer Inst Inc
Publication of FI893916A0 publication Critical patent/FI893916A0/fi
Publication of FI893916A publication Critical patent/FI893916A/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70546—Integrin superfamily
    • C07K14/70553—Integrin beta2-subunit-containing molecules, e.g. CD11, CD18
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Materials For Medical Uses (AREA)
FI893916A 1988-08-23 1989-08-21 Alfa-subenhet av lfa-1 -leukocytadhesionsreceptor. FI893916A (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US23522788A 1988-08-23 1988-08-23
US32101789A 1989-03-09 1989-03-09

Publications (2)

Publication Number Publication Date
FI893916A0 true FI893916A0 (fi) 1989-08-21
FI893916A FI893916A (fi) 1990-02-24

Family

ID=26928699

Family Applications (1)

Application Number Title Priority Date Filing Date
FI893916A FI893916A (fi) 1988-08-23 1989-08-21 Alfa-subenhet av lfa-1 -leukocytadhesionsreceptor.

Country Status (14)

Country Link
EP (1) EP0362526B1 (fi)
JP (1) JPH02306999A (fi)
KR (1) KR900002796A (fi)
AT (1) ATE123810T1 (fi)
AU (1) AU634974B2 (fi)
DE (1) DE68923048T2 (fi)
DK (1) DK412589A (fi)
ES (1) ES2075016T3 (fi)
FI (1) FI893916A (fi)
GR (1) GR3017303T3 (fi)
HU (1) HUT53673A (fi)
IL (1) IL91369A (fi)
NO (1) NO893366L (fi)
PT (1) PT91503B (fi)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1988006592A1 (en) * 1987-02-26 1988-09-07 Dana-Farber Cancer Institute, Inc. Cloning of lfa-1
US5395929A (en) * 1987-12-15 1995-03-07 Dana Farber Cancer Institute Isolated nucleic acid encoding the alpha subunit of the human leukocyte adhesion receptor
US6051231A (en) * 1988-09-01 2000-04-18 Bayer Corporation Antiviral methods and prepations
ZA896668B (en) * 1988-09-01 1990-06-27 Molecular Therapeutics Inc A human rhinovirus receptor protein that inhibits virus infectivity
EP0362531B1 (en) 1988-09-01 1999-11-10 Bayer Corporation A human rhinovirus receptor protein that inhibits virus infectivity
US6514936B1 (en) 1988-09-01 2003-02-04 Bayer Corporation Antiviral methods using human rhinovirus receptor (ICAM-1)
US6143298A (en) * 1988-09-01 2000-11-07 Bayer Corporation Soluble truncated forms of ICAM-1
WO1990010652A1 (en) * 1989-03-09 1990-09-20 Dana Farber Cancer Institute Method of treating viral infections using lfa-1
CA2050326A1 (en) * 1989-03-09 1990-09-10 Angel A. Corbi Leukocyte adhesion receptors
US5686582A (en) * 1990-07-20 1997-11-11 Bayer Corporation Multimeric forms of human rhinovirus receptor protein
US6107461A (en) * 1990-07-20 2000-08-22 Bayer Corporation Multimeric forms of human rhinovirus receptor and fragments thereof, and method of use
DE69131564T2 (de) * 1990-07-20 2000-01-13 Bayer Corp., Pittsburgh Multimere Formen des menschlichen Rhinovirus-Rezeptorproteins
US5686581A (en) * 1990-07-20 1997-11-11 Bayer Corporation Multimeric form of human rhinovirus receptor protein
US5120830A (en) * 1990-10-25 1992-06-09 Washington University Inhibitory peptides against α-2, β-1 mediated mg++ dependent adhesion of platelets to collagen
US5629287A (en) * 1991-01-18 1997-05-13 University College London Depot formulations
US5610148A (en) * 1991-01-18 1997-03-11 University College London Macroscopically oriented cell adhesion protein for wound treatment
JPH09512021A (ja) * 1994-04-19 1997-12-02 ザ ユニバーシティ オブ カンサス Ｉｃａｍ−１／ｌｆａ−１ 短鎖ペプチドおよび該ペプチドの使用方法
US6017734A (en) * 1995-07-07 2000-01-25 The Texas A & M University System Unique nucleotide and amino acid sequence and uses thereof
US6075004A (en) * 1996-04-26 2000-06-13 The University Of Kansas Peptide compositions which induce immune tolerance and methods of use
AU4825699A (en) * 1998-06-19 2000-01-05 Genzyme Corporation Identification and use of differentially expressed genes and polynucleotide sequences
AU4971699A (en) * 1998-07-06 2000-01-24 Bai Luo Hyaluronic acid mimics and methods related thereto
DK1512695T3 (da) * 2003-09-04 2009-03-16 Biomay Ag Hypoallergeniske polypeptider på fiske-parvalbumin
PL1682537T3 (pl) 2003-11-05 2012-09-28 Sarcode Bioscience Inc Modulatory adhezji komórkowej
US20060122377A1 (en) 2004-02-19 2006-06-08 Genentech, Inc. CDR-repaired antibodies
JP5794721B2 (ja) 2005-05-17 2015-10-14 サーコード バイオサイエンス インコーポレイテッド 眼障害の治療のための組成物および方法
AU2008317473B2 (en) 2007-10-19 2014-07-17 Bausch + Lomb Ireland Limited Compositions and methods for treatment of diabetic retinopathy
WO2009139817A2 (en) 2008-04-15 2009-11-19 Sarcode Corporation Crystalline pharmaceutical and methods of preparation and use thereof
WO2011050175A1 (en) 2009-10-21 2011-04-28 Sarcode Corporation Crystalline pharmaceutical and methods of preparation and use thereof
AU2013295706A1 (en) 2012-07-25 2015-02-19 Sarcode Bioscience Inc. LFA-1 inhibitor and polymorph thereof

Also Published As

Publication number Publication date
DK412589A (da) 1990-02-24
AU634974B2 (en) 1993-03-11
NO893366D0 (no) 1989-08-22
DE68923048T2 (de) 1995-11-16
IL91369A (en) 1994-08-26
JPH02306999A (ja) 1990-12-20
IL91369A0 (en) 1990-04-29
PT91503A (pt) 1990-03-08
EP0362526A2 (en) 1990-04-11
EP0362526B1 (en) 1995-06-14
EP0362526A3 (en) 1990-07-18
PT91503B (pt) 1996-04-30
DE68923048D1 (de) 1995-07-20
ES2075016T3 (es) 1995-10-01
GR3017303T3 (en) 1995-12-31
ATE123810T1 (de) 1995-06-15
HUT53673A (en) 1990-11-28
FI893916A (fi) 1990-02-24
NO893366L (no) 1990-02-26
AU4014589A (en) 1990-03-01
DK412589D0 (da) 1989-08-22
KR900002796A (ko) 1990-03-23

Similar Documents

Publication Publication Date Title
FI893916A0 (fi) Alfa-subenhet av lfa-1 -leukocytadhesionsreceptor.
EP0364690A3 (en) The alpha-subunit of the mac-1 leukocyte adhesion receptor
IL86246A0 (en) Intercellular adhesion molecules and functional derivatives thereof,their production and antibodies against thereto
NZ232833A (en) Intercellular adhesion molecule-2 (icam-2) and functional derivatives thereof
ATE246245T1 (de) Interzellulare adhäsions-moleküle und deren bindungsliganden

Legal Events

Date Code Title Description
MM Patent lapsed

Owner name: DANA FARBER CANCER INSTITUTE